Pharmaceutical compound
Clinical data | |
---|---|
Other names | BRL 14342 |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C17H20ClNO |
Molar mass | 289.80 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Clemeprol is an serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant and anticholinergic agent.
It is an enantiomeric mixture of R and S isomers. Both isomers show similar pharmacological activity.
Synthesis
A synthetic pathway for clemeprol is disclosed:
The Corey-Chaykovsky epoxidation between 3-chlorobenzophenone (1) and dimethylsulfoxonium methylide (Corey's reagent) , gives 2-(3-chlorophenyl)-2-phenyloxirane (2). Further reaction with boron trifluoride etherate gives m-chlorophenyl-phenylacetaldehyde, PC12549135 (3). A second Corey-Chaykovsky epoxidation gives 2-oxirane, PC12549073 (4). Quenching with dimethylamine completes the synthesis of clemeprol (5).
See also
References
- Dictionary of Pharmacological Agents By C.R. Ganellin, David J. Triggle.
- Clark MS, Johnson AM, McClelland GR, Nelson DR (December 1980). "Pharmacological and biochemical properties of BRL 14342, a novel potential antidepressant drug". Neuropharmacology. 19 (12): 1207–8. doi:10.1016/0028-3908(80)90203-8. PMID 7442949.
- Koch, H., Drugs Future, 1983,8, 194.
- Clark JA, Clark MS, Gardner DV, Gaster LM, Hadley MS, Miller D, et al. (November 1979). "Substituted 3-amino-1,1-diaryl-2-propanols as potential antidepressant agents". Journal of Medicinal Chemistry. 22 (11): 1373–9. doi:10.1021/jm00197a018. PMID 533885.
- Anon., GB1448437 (1976-09-08 to Beecham Group Ltd).
- Judith Ann Clark, US4101676 & US4113972 (1978 to Beecham Group PLC).
- Judith Ann Clark, US4056630 (1977 to Beecham Group PLC).
- CA1049530 idem Judith Ann Clark, US4028415 (1977 to Beecham Group PLC).
Anxiolytics (N05B) | |
---|---|
5-HT1ARTooltip 5-HT1A receptor agonists | |
GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators |
|
Hypnotics | |
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Antipsychotics | |
Sympatholytics (Antiadrenergics) |
|
Others | |
|
Neuropathic pain and fibromyalgia pharmacotherapies | |
---|---|
Monoaminergics |
|
Ion channel blockers |
|
Others |
|
Monoamine reuptake inhibitors | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DATTooltip Dopamine transporter (DRIsTooltip Dopamine reuptake inhibitors) |
| ||||||||||||||
NETTooltip Norepinephrine transporter (NRIsTooltip Norepinephrine reuptake inhibitors) |
| ||||||||||||||
SERTTooltip Serotonin transporter (SRIsTooltip Serotonin reuptake inhibitors) |
| ||||||||||||||
VMATsTooltip Vesicular monoamine transporters | |||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |